Cullinan Oncology LLC (CGEM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $15.21
• Market Cap: $843.02M
• EPS: $-3.32
• 52-Week High: $14.56
• 52-Week Low: $5.68

Market Sentiment

Cullinan Oncology LLC currently has a Bullish sentiment score of 0.27.

About Cullinan Oncology LLC

Cullinan Oncology LLC is a dynamic biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on pioneering targeted oncology and immuno-oncology therapies to enhance outcomes for cancer patients. Committed to innovation and strategic partnerships, Cullinan is developing a diverse pipeline of therapeutic candidates that address significant unmet medical needs in the oncology sector. By harnessing state-of-the-art science and technology, the company aims to revolutionize canc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cullinan Oncology LLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CGEM pay dividends?

Cullinan Oncology LLC (CGEM) does not currently pay a regular dividend.

What is CGEM's market cap?

Cullinan Oncology LLC (CGEM) has a market capitalization of $843.02M with a current stock price of $15.21.